DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma

被引：0
|
作者：
Thomas Fleischer
Hege Edvardsen
Jovana Jovanovic
Nizar Touleimat
Anne-Lise Børresen-Dale
Jörg Tost
Vessela N Kristensen
机构：
[1] Oslo University Hospital Radiumhospitalet,Department of Genetics, Institute for Cancer Research
[2] University of Oslo,The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine
[3] University of Oslo,Institute for Clinical Epidemiology and Molecular Biology (EpiGen), Faculty of Medicine
[4] Centre National de Génotypage,Laboratory for Epigenetics
[5] CEA - Institut de Génomigue,undefined
来源：
Epigenetics & Chromatin | / 6卷 / Suppl 1期
关键词：
Breast Cancer; Invasive Carcinoma; Mammographic Density; Gene Body; Inhibit Gene Expression;
D O I：
10.1186/1756-8935-6-S1-P18
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma
    Kathryn C. Behling
    Amy Tang
    Boris Freydin
    Inna Chervoneva
    Sameep Kadakia
    Gordon F. Schwartz
    Hallgeir Rui
    Agnieszka K. Witkiewicz
    Breast Cancer Research and Treatment, 2011, 129 : 717 - 724
  • [42] Is carcinoma in situ a precursor lesion of invasive breast cancer?
    To, Teresa
    Wall, Claus
    Baines, Cornelia J.
    Miller, Anthony B.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (07) : 1646 - 1652
  • [43] Morphometric signature identifies ductal carcinoma in situ of the breast with low risk of progression to invasive breast cancer
    Sobral-Leite, Marcelo
    Castillo, Simon
    Vonk, Shiva
    Melillo, Xenia
    Lam, Noomie
    de Bruijn, Brandi
    Hagos, Yeman
    Sanders, Joyce
    Almekinders, Mathilde
    Visser, Lindy
    Groen, Emilie
    Van der Borden, Carolien
    Kristel, Petra
    Caner, Ercan
    Azarang, Leyla
    Yuan, Yinyin
    Menezes, Renee
    Lips, Esther
    Wesseling, Jelle
    CANCER RESEARCH, 2024, 84 (09)
  • [44] Lobular carcinoma in situ and invasive lobular cancer of the breast
    Cocquyt, V
    Van Belle, S
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2005, 17 (01) : 55 - 60
  • [45] Tenascin patterns of expression in duct carcinoma in situ of the breast
    Iskaros, BF
    Sison, CP
    Hajdu, SI
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2000, 30 (03): : 266 - 271
  • [46] Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma
    Peyrol, S
    Raccurt, M
    Gerard, F
    Gleyzal, C
    Grimaud, JA
    Sommer, P
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (02): : 497 - 507
  • [47] Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression
    Chen, Guang
    Ding, Xiao-Fei
    Pressley, Kyle
    Bouamar, Hakim
    Wang, Bingzhi
    Zheng, Guixi
    Broome, Larry E.
    Nazarullah, Alia
    Brenner, Andrew J.
    Kaklamani, Virginia
    Jatoi, Ismail
    Sun, Lu-Zhe
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1486 - 1496
  • [48] Expression patterns of β-catenin in in situ and invasive breast cancer
    Karayiannakis, AJ
    Nakopoulou, L
    Gakiopoulou, H
    Keramopoulos, A
    Davaris, PS
    Pignatelli, M
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (01): : 31 - 36
  • [49] BRCA1 and PARP1 mRNA expression during progression from normal breast to ductal carcinoma in situ and invasive breast cancer
    Hybiak, J.
    Domagala, P.
    Domagala, W.
    VIRCHOWS ARCHIV, 2015, 467 : S14 - S14
  • [50] Clonal Evolution in the Progression from Ductal Carcinoma In Situ To Invasive Ductal Carcinoma
    Lee, Ju Youn
    Bi, Rui
    Geyer, Felipe
    Wen, Hannah Y.
    Lim, Raymond S.
    Hicks, James
    Weigelt, Britta
    Reis-Filho, Jorge
    MODERN PATHOLOGY, 2018, 31 : 84 - 85
12345